These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 88539)

  • 21. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
    Berthier-Vergnes O; Portoukalian J; Lefthériotis E; Doré JF
    Cancer Res; 1994 May; 54(9):2433-9. PubMed ID: 8162593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
    Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
    Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers.
    Coggin JH; Barsoum AL; Rohrer JW
    Anticancer Res; 1999; 19(6C):5535-42. PubMed ID: 10697612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serological analysis of melanoma patients receiving autologous melanoma cell vaccines].
    Watanabe T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):261-72. PubMed ID: 6881976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
    Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG).
    Minden P; Sharpton TR; McClatchy JK
    J Immunol; 1976 May; 116(5):1407-14. PubMed ID: 58033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
    Kirkwood JM; Vlock DR
    Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen.
    Hoon DS; Yuzuki D; Hayashida M; Morton DL
    J Immunol; 1995 Jan; 154(2):730-7. PubMed ID: 7814879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
    Kan-Mitchell J; White WL; Mitchell MS
    Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-induced movement of common melanoma membrane antigens on the surface of unfixed human melanoma cells.
    Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET
    Cancer Res; 1979 Jun; 39(6 Pt 1):2125-31. PubMed ID: 376115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
    Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
    J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of oncofetal antigen-I (OFA-I) on lymphocyte response in pregnant women].
    Kajino T; Kanazawa K; Takakuwa K; Sasagawa M; Maruhashi T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):845-52. PubMed ID: 2942615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of antisera with specificity for malignant melanoma and human fetal skin.
    Fritze D; Kern DH; Drogemuller CR; Pilch YH
    Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue distribution, molecular profile, and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells.
    Natali PG; Wilson BS; Imai K; Bigotti A; Ferrone S
    Cancer Res; 1982 Feb; 42(2):583-9. PubMed ID: 6173115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganglioside GM2 as a human tumor antigen (OFA-I-1).
    Tai T; Paulson JC; Cahan LD; Irie RF
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5392-6. PubMed ID: 6193515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells.
    Harper JR; Bumol TF; Reisfeld RA
    J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
    Ravindranath MH; Morton DL; Irie RF
    Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
    Hamby CV; Liao SK; Kanamaru T; Ferrone S
    Cancer Res; 1987 Oct; 47(20):5284-9. PubMed ID: 3115563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human melanoma and leukemia associated antigens difined by nonhuman primate antisera.
    Seigler HF; Metzgar RS; Mohanakumar T; Stuhlmiller GM
    Fed Proc; 1975 Jul; 34(8):1642-6. PubMed ID: 805717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of a human sarcoma-associated antigen with monoclonal antibodies.
    Brown JM
    Cancer Res; 1983 May; 43(5):2113-20. PubMed ID: 6299540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.